Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanisms
HAART 治疗患者中的病毒库和庇护所:作用和机制
基本信息
- 批准号:8202570
- 负责人:
- 金额:$ 45.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-08 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAnti-Retroviral AgentsBloodBone MarrowCD4 Positive T LymphocytesCellsChemistryChronicCollagenCompetenceComplementDNADepositionFibrosisFutureGeneticGenetic TranscriptionGoalsGut associated lymphoid tissueHIVHIV InfectionsHIV therapyHematopoietic and Lymphoid TissueHematopoietic stem cellsHighly Active Antiretroviral TherapyInfectionIntegration Host FactorsInterventionLaboratoriesLarge IntestineLeukapheresisLifeLymph Node TissueLymphoid CellLymphoid TissueMacacaMeasurementMeasuresMemoryMindNatureNucleic AcidsPatientsPatternPeripheralPhenotypePlasmaPopulationPopulation GeneticsRNARNA SplicingRelative (related person)ResearchResidual stateRestRoleSamplingSiteSmall IntestinesSourceStructureSurveysT-Lymphocyte SubsetsTechniquesTissuesTranscriptViralViral Load resultViremiaVirusWorkantiretroviral therapybasecell typedesigngenetic analysisinnovationlymph nodesmacrophagememory CD4 T lymphocytenew technologynonhuman primatenovelperipheral blood
项目摘要
Identifying where HIV persists in HIV-infected patients on suppressive therapy is a critically important step
towards HIV eradication. For practical reasons, the study of viral reservoirs has largely focused on
components of peripheral blood. Recent findings, however, show that tissue sites harbor a substantial
proportion of infected cells. The overall goal of this Project is to identify the source, dynamics, and nature of
the reservoir producing persistent HIV infection in patients on suppressive therapy in a range of tissue sites.
The research team will determine the nature of HIV persistence/latency in T-cell subsets (naive, memory,
central memory and effector/transitional memory) and hematopoietic progenitor cells from the small bowel,
large bowel, lymph nodes, and bone marrow of patients on long-term therapy (>7 years) who initiated
therapy during acute and chronic infection. We will also investigate HIV in rare circulating cells (which will be
obtained from leukapheresis). Unique and innovative techniques will be used to (1) analyze the genetic
make-up of HIV populations in the cell subsets, (2) quantify the levels of intracellular HIV DNA and unspliced
RNA/spliced RNA and, using a novel nucleic acid chemistry for primer-probe design, measure short abortive
HIV transcripts, (3) determine the replication competence of the HIV remaining in different cellular subsets,
(4) reveal host cell factors that determine which cells may harbor or resist replicating and/or latent HIV and
(5) examine the effect of collagen deposition and fibrosis on the size and distribution of the reservoirs. We
will also support complementary work being done in tissue-based macrophages (Project 4). In addition to
understanding how HIV is subdivided among different cells and tissues, the proposed study will provide a
systematic survey of how lymphoid cell host factors and changes in lymph node tissue structure support HIV
latency and help determine the magnitude and nature of the viral reservoirs. We believe that this study will
provide an unprecedented quantitative assessment of total body stores of virus and that our findings will
guide treatment interventions that can reduce and eradicate persistent HIV reservoirs.
确定艾滋病毒在接受抑制治疗的艾滋病毒感染患者中的持续存在是至关重要的一步
致力于根除艾滋病由于实际原因,病毒储库的研究主要集中在
外周血的成分。然而,最近的研究结果表明,组织部位含有大量的
感染细胞的比例。本项目的总体目标是确定的来源,动力学,和性质
在一系列组织部位的抑制治疗中,储存库产生持续的HIV感染。
研究小组将确定艾滋病毒在T细胞亚群(幼稚,记忆,
中枢记忆和效应/过渡记忆)和来自小肠的造血祖细胞,
大肠、淋巴结和骨髓的长期治疗(>7年)患者,
治疗急性和慢性感染。我们还将研究罕见的循环细胞中的艾滋病毒(这将是
从白细胞分离术中获得)。独特和创新的技术将用于(1)分析基因
细胞亚群中HIV群体的组成,(2)定量细胞内HIV DNA和未剪接的水平,
RNA/剪接的RNA,并使用一种新的核酸化学引物探针设计,测量短败育
HIV转录本,(3)决定HIV在不同细胞亚群中的复制能力,
(4)揭示宿主细胞因子,其决定哪些细胞可能窝藏或抵抗复制和/或潜伏的HIV,
(5)检查胶原沉积和纤维化对储库大小和分布的影响。我们
还将支持在基于组织的巨噬细胞中进行的补充工作(项目4)。除了
了解艾滋病毒是如何在不同的细胞和组织中细分的,这项拟议的研究将提供一个
淋巴细胞宿主因子和淋巴结组织结构变化如何支持HIV的系统调查
潜伏期和帮助确定病毒库的大小和性质。我们相信这项研究将
提供了一个前所未有的定量评估的总身体储存的病毒,我们的研究结果将
指导治疗干预措施,以减少和根除持续存在的艾滋病毒宿主。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Elizabeth Palmer其他文献
Sarah Elizabeth Palmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah Elizabeth Palmer', 18)}}的其他基金
Combining immunogenic peptides and Nef blockade to enhance CD8 T-cell-mediated clearance of HIV-infected cells
结合免疫原性肽和 Nef 阻断来增强 CD8 T 细胞介导的 HIV 感染细胞清除
- 批准号:
10685405 - 财政年份:2022
- 资助金额:
$ 45.13万 - 项目类别:
Combining immunogenic peptides and Nef blockade to enhance CD8 T-cell-mediated clearance of HIV-infected cells
结合免疫原性肽和 Nef 阻断来增强 CD8 T 细胞介导的 HIV 感染细胞清除
- 批准号:
10482443 - 财政年份:2022
- 资助金额:
$ 45.13万 - 项目类别:
Genetic analysis of unspliced HIV RNA produced during HDAC inhibitor therapy
HDAC 抑制剂治疗期间产生的未剪接 HIV RNA 的遗传分析
- 批准号:
8730254 - 财政年份:2014
- 资助金额:
$ 45.13万 - 项目类别:
Targeting_the_Source_of_Persistent_HIV_Viremia
持续性 HIV 病毒血症的目标来源
- 批准号:
8047422 - 财政年份:2010
- 资助金额:
$ 45.13万 - 项目类别:
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanisms
HAART 治疗患者中的病毒库和庇护所:作用和机制
- 批准号:
8500171 - 财政年份:
- 资助金额:
$ 45.13万 - 项目类别:
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanisms
HAART 治疗患者中的病毒库和庇护所:作用和机制
- 批准号:
8376036 - 财政年份:
- 资助金额:
$ 45.13万 - 项目类别:
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanisms
HAART 治疗患者中的病毒库和庇护所:作用和机制
- 批准号:
8892978 - 财政年份:
- 资助金额:
$ 45.13万 - 项目类别:
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanisms
HAART 治疗患者中的病毒库和庇护所:作用和机制
- 批准号:
8703600 - 财政年份:
- 资助金额:
$ 45.13万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 45.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 45.13万 - 项目类别:
Operating Grants